title: Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis.
abstract: BACKGROUND
  It is believed that severe portal hypertensive gastropathy probably accounts for most non-variceal bleeding episodes in patients with cirrhosis. Gastric antral vascular ectasia (GAVE) also occurs in these patients. It is not clear whether it is a variant of portal hypertensive gastropathy or a distinct condition.
  
  
  METHODS
  A patient, a 66 year od woman, with cirrhosis initially diagnosed as having portal hypertensive gastropathy and subsequently classified as GAVE is described. She required transfusion with a total of 130 units of packed red cells for gastrointestinal blood loss.
  
  
  RESULTS
  The bleeding did not respond to portal decompression with TIPS or beta blockers. Following treatment with oral tranexamic acid she has not required further blood transfusion over a period of 30 months.
  
  
  CONCLUSIONS
  Tranexamic acid may be a useful treatment for refractory bleeding due to gastric antral vascular ectasia in patients with cirrhosis.
authors.affiliation: Liver Unit, St Vincent's Hospital, Dublin, Ireland.
authors.forename: P A
authors.initials: PA
authors.lastname: McCormick
authors.forename: H
authors.initials: H
authors.lastname: Ooi
authors.forename: O
authors.initials: O
authors.lastname: Crosbie
mesh_terms: D000368:Aged; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D013272:Stomach Diseases / Q000150:complications*; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000150:complications*
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid